SCHEMBL3345432

SCHEMBL3345432

CC(=O)Nc1ccc2c(c1)Cc1cc(F)ccc1-2

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.70
▸ ADRA2A P08913 1/20 0.70
▸ MAOA P21397 1/20 0.70
▸ SLC6A2 P23975 1/20 0.70
▸ HTR2C P28335 1/20 0.70
▸ SLC6A4 P31645 1/20 0.70
▸ HTR2B P41595 1/20 0.70
▸ HSP90AA1 P07900 1/20 0.59
▸ TLR9 Q9NR96 1/20 0.59
▸ CYP2C9 P11712 1/20 0.59
▸ HIF1A Q16665 1/20 0.59
▸ SLC1A3 P43003 1/20 0.59
▸ SLC1A2 P43004 1/20 0.59
▸ SLC1A1 P43005 1/20 0.59
▸ RAB9A P51151 5/20 0.57
▸ NPC1 O15118 3/20 0.57
▸ KMT2A Q03164 2/20 0.56
▸ BAZ2B Q9UIF8 1/20 0.52
▸ POLB P06746 2/20 0.51
▸ MEN1 O00255 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2962505 0.90 MAOA (0.84) CYP1A2ADRA2AMAOASLC6A2HTR2C
2-Acetylaminofluorene SCHEMBL21114365 0.83 CYP1A2 (1.00) CYP1A2ADRA2AMAOASLC6A2HTR2C
2-Acetylaminofluorene SCHEMBL29364009 0.83 CYP1A2 (1.00) CYP1A2ADRA2AMAOASLC6A2HTR2C
2-Acetylaminofluorene SCHEMBL29829339 0.83 CYP1A2 (1.00) CYP1A2ADRA2AMAOASLC6A2HTR2C
2-Acetylaminofluorene SCHEMBL75140 0.83 CYP1A2 (1.00) CYP1A2ADRA2AMAOASLC6A2HTR2C
SCHEMBL4380156 0.81 MAOA (0.70) CYP1A2ADRA2AMAOASLC6A2HTR2C
2-Acetylaminofluorene SCHEMBL6903872 0.81 CYP1A2 (0.97) CYP1A2ADRA2AMAOASLC6A2HTR2C
2-Acetylaminofluorene SCHEMBL5663545 0.78 CYP1A2 (0.89) CYP1A2ADRA2AMAOASLC6A2HTR2C
SCHEMBL28178463 0.76 CYP1A2 (0.88) CYP1A2ADRA2AMAOASLC6A2HTR2C
Water SCHEMBL8927845 0.76 CYP1A2 (0.62) CYP1A2ADRA2AMAOASLC6A2HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100162416-A1 Multi-stage stem cell carcinogenesis STEMLIFELINE, INC. (US) 2010-06-24 — — US disclosed
WO-2010037134-A2 MULTI-STAGE STEM CELL CARCINOGENESIS STEMLIFELINE, INC. (US) 2010-04-01 — — WO disclosed
Send feedback